Table 1.

Clinical and neuropathological characteristics of brain samples for synucleinopathy and non-synucleinopathy controls

Control samples were selected to match MSA and PD samples for a range of tau and amyloid pathology patterns. DLBD, diffuse lewy body disease; *, MSA-nigrostriatal type; ADNC, Alzheimer disease neuropathologic change; AGD, argyrophilic grain disease; TDP-MTL, TDP-43 proteinopathy in medial temporal lobe; ALS, amyotrophic lateral sclerosis; PART, primary age-related tauopathy.